Ether linked triazoles as NRF2 activators

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12091409
SERIAL NO

17350183

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to ether-linked triazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the invention relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTEX THERAPEUTICS LIMITEDCAMBRIDGE CAMBRIDGESHIRE CB4 0QA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cooper, Anthony William James Stevenage, GB 26 98
Goodwin, Nicole Cathleen King of Prussia, US 17 39
Griffiths-Jones, Charlotte Mary Cambridge, GB 36 210
Heightman, Thomas Daniel Cambridge, GB 48 214
Kerns, Jeffrey K King of Prussia, US 30 157
Willems, Hendrika Maria Gerarda Cambridge, GB 11 47
Yan, Hongxing King of Prussia, US 30 131

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 17, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 17, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 17, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00